Citations 1
OT03 | BGB‐11417‐302, A PHASE 3, RANDOMIZED, DOUBLE‐BLIND STUDY OF SONROTOCLAX (BGB‐11417) + ZANUBRUTINIB VERSUS PLACEBO + ZANUBRUTINIB IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA
Dreyling, M., Eyre, Toby A. , Alalade, H., Maksimova, Elena , Li, Xinyu , Wang, Limei , Dreyling, Martin , Hughes, M., Song, Yuqin , Wang, Yanan , Zhang, J., Maksimova, E., Li, X., Xu, Zhiheng , To, C.
Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available
